English
8 pages. Includes bibliography. Treatment-resistant depression affects nearly 3 million people in the United States. In the early 2000s, researchers began looking at ketamine as a possible treatment. Decades of research supported by the National Institute of Mental Health led to the 2019 approval of esketamine for treatment-resistant depression.
Sign in with your free account to read, download EPUBs or listen.
mental health · psychiatric · psychology · treatment · pharmacotherapy · depression · ketamine · research